Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph not_applicable
3
43%
Ph phase_2
2
29%
Ph phase_1
1
14%
Ph phase_3
1
14%

Phase Distribution

1

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution7 total trials
Phase 1Safety & dosage
1(14.3%)
Phase 2Efficacy & side effects
2(28.6%)
Phase 3Large-scale testing
1(14.3%)
N/ANon-phased studies
3(42.9%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

57.1%

4 of 7 finished

Non-Completion Rate

42.9%

3 ended early

Currently Active

0

trials recruiting

Total Trials

7

all time

Status Distribution
Completed(4)
Terminated(3)

Detailed Status

Completed4
Withdrawn3

Development Timeline

Analytics

Development Status

Total Trials
7
Active
0
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 11 (14.3%)
Phase 22 (28.6%)
Phase 31 (14.3%)
N/A3 (42.9%)

Trials by Status

withdrawn343%
completed457%

Recent Activity

0 active trials
Showing 5 of 7
withdrawnphase_2

Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV

NCT00021762
completedphase_1

Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV

NCT00842634
withdrawnnot_applicable

Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents

NCT00067574
completednot_applicable

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

NCT00100646
withdrawnnot_applicable

Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV

NCT00084032
View all 7 trials

Clinical Trials (7)

Showing 7 of 7 trials
NCT00021762Phase 2

Effects of Immunization With HIV-1 Immunogen Plus Anti-HIV Treatment Interruption on the Levels of HIV

Withdrawn
NCT00842634Phase 1

Autologous T-Cells Genetically Modified at the CCR5 Gene by Zinc Finger Nucleases SB-728 for HIV

Completed
NCT00067574Not Applicable

Treatment Plan to Decrease Drug Exposure in HIV Infected Adolescents

Withdrawn
NCT00100646Not Applicable

Anti-HIV Treatment Interruptions in HIV Infected Adults in South Africa

Completed
NCT00084032Not Applicable

Anti-HIV Medications and Structured Treatment Interruptions for People Recently Infected With HIV

Withdrawn
NCT00820118Phase 2

Early and Intermittent Antiretroviral Therapy in Naive HIV Infected Adults

Completed
NCT00158405Phase 3

Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)

Completed

All 7 trials loaded

Drug Details

Intervention Type
BEHAVIORAL
Total Trials
7